☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Lantern Pharma
Lantern Pharma Reports the First Patient Dosing of LP-184 in the P-I Study for Advanced Solid Tumors Shots: The first patient ha...
September 26, 2023
Load more...
Back to Home